EV/EBITDA
-22.77
+1.19+4.97%
Fri, 07 Feb 2025 21:01:56 GMT
Summary
- As of February 8, 2025, MLTX EV/EBITDA is -22.77, with a rise of +1.19 (+4.97%) during the most recent trading day.
- Over the past year, MLTX EV/EBITDA has increased by +36.56 (+61.62%).
- MLTX EV/EBITDA is now -796.46% below its all-time high of -2.54.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.0% | -5.0% | -4.3% |
| 1 m1 month | +11.6% | -11.6% | -10.3% |
| 3 m3 months | +12.5% | -12.5% | -11.1% |
| 6 m6 months | +28.3% | -0.7% | +0.3% |
| ytdytd | +18.9% | -18.8% | -16.8% |
| 1 y1 year | +61.6% | -23.1% | -25.5% |
| 5 y5 years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.1% | -25.77 | +11.6% | |
| 3 m | 3-month | -21.46 | -6.1% | -29.31 | +22.3% |
| 6 m | 6-month | -21.46 | -6.1% | -40.25 | +43.4% |
| 1 y | 1-year | -21.46 | -6.1% | -63.12 | +63.9% |
| 3 y | 3-year | -2.54 | -796.5% | -63.12 | +63.9% |
| 5 y | 5-year | -2.54 | -796.5% | -63.12 | +63.9% |
| alltime | all time | -2.54 | -796.5% | -63.12 | +63.9% |
MoonLake Immunotherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -22.77(-18.9%) |
| 2024 | -28.06(-52.6%) |
| Date | Value |
|---|---|
| 2023 | -59.22(+895.3%) |
| 2022 | -5.95 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -22.77
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +5.29 (+18.85%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +36.56 (+61.62%)